OssDsign released its Q1 report after a profit warning on 10 April.
Redeye comments on the announced outcome of ExpreS2ion’s recent rights issue, which was subscribed t...
* Q1 in line with pre-announced numbers * Minor estimate revisions, H2'26 the key catalyst * Fair va...
* Approval for Selektope extended again, now until Dec '26 * Ongoing process could not be finalised ...
Redeye provides its initial take on Collaxio Q1 2026 report, which featured a flat NAV development q...
Voi, som är det näst största innehavet i VNV Global, kom med en mycket stark Q1-rapport för en vecka...
Xbrane's Q1 report showed a continued pressured outlook for Ximluci, with the volume growth in the q...
Redeye provides an initial comment on Tradedoubler’s Q1 2026 report, published this morning.
As expected, sales and order bookings were rather muted in the first quarter.
* Net sales SEK 201m, +1% vs ABGSCe * EBITA SEK 28m vs ABGSCe SEK 27m * The share is trading at 7-6x...
Hoenle looks set to report its Q2 25/26 results (covering January - March 2026) on 13th of May.
Nabaltec published final Q4 figures, confirmed the FY26 guidance and released preliminary Q1 numbers...
Yesterday, BVB published preliminary Q3 figures, that clearly display the effect of the UCL play off...
OssDsign today released its full Q1 following the profit warning on 10 April.
Redeye initiates coverage of Goodbye Kansas Group, a company specialising in digital visual content ...
Redeye updates its estimates and valuation following MedCap’s Q1 2026 report.
Siili’s CEO Tomi Pienimäki is leaving his position.
Redeye comments on the announced outcome of Magle’s recent rights issue, which was subscribed to app...
Endomines completed a share split on April 29th, and we have adjusted our estimates accordingly.
SinterCast rapporterar ett svagare första kvartal med lägre försäljning och resultat, men behåller h...
